Published in Cancer Weekly, February 24th, 1997
"ImmunoCyt 1 represents a major breakthrough in bladder cancer detection," said Serge Pitre, DiagnoCure Inc., Montreal, Quebec, Canada. "Our trials, conducted on a sampling of 251 different cases from various regions of Canada, demonstrate that this diagnostic test is superior to all non-invasive methods currently used in the world. It will contribute to significantly improving the chances of early detection and to facilitating patient treatment."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.